Euronext Dublin's 2019 IPO Ready strategic financing programme gets underway
Euronext announces nominations to the Managing Board and Supervisory Board
Date
Short Title
EGM 8/10/2019
Show Detail
Show Detail
An Extraordinary General Meeting (EGM) of Euronext N.V. was held on Tuesday 8 October 2019 at 11.00 a.m. CET at the offices of Euronext N.V. at Beursplein 5, 1012 JW Amsterdam, the Netherlands.
All the items on the updated agenda were approved. These items were as follows:
Authored on
5 years 10 months ago
Language
English
Name
Convening notice EGM 8 October 2019
Thumbnail
Authored by
sclediere
Authored on
5 years 10 months ago
Language
English
Name
Agenda to the EGM 8 October 2019
Thumbnail
Authored by
sclediere
Authored on
5 years 9 months ago
Language
English
Name
Euronext 5 years after the IPO
Thumbnail
Authored by
sclediere
Authored on
5 years 9 months ago
Language
English
Name
Additional details for the item 4 of the Extraordinary General Meeting of Euronext N.V. on 8 October 2019
Thumbnail
Authored by
Ariel
Authored on
5 years 8 months ago
Language
English
Name
Voting results EGM 8 October 2019
Thumbnail
Authored by
Ariel
Authored on
5 years 6 months ago
Language
English
Name
Minutes EGM 8 October 2019
Thumbnail
Authored by
Ariel
Euronext announces volumes for July 2019
Euronext publishes Q2 results
Italy-based Media-Maker lists on Euronext Growth
Understand investors better: the evolution of ESG in asset management
New City Initiative, a think tank comprised of 45 leading independent asset management firms from the UK, has published a report about the evolution of ESG in asset management. Read the insights from the asset managers interviewed.
Executive Summary
Over the last five years, ESG investing has matured from being primarily an esoteric capital allocation tool to becoming part of the fabric of modern-day asset management. There have been a number of reasons why ESG is becoming so popular among managers of all sizes ranging from retail and institutional investor pressure right through to the potential return benefits. With EU regulators now actively pushing investment firms into adopting ESG, NCI analyses how boutique asset managers are applying sustainability in their businesses.
Titan Cement International lists on Euronext Brussels and Euronext Paris
Aerkomm lists on Euronext Paris
Market Insights from our Post-Listing Advisory team
Nicolas Meunier
Head of Post-Listing Advisory
In each newsletter, our Post-Listing Advisory team shares some insights to support your journey on capital markets. Our first market insight is on biotechs.
Despite lower amounts of capital raised by listed biotechs on equity capital markets in the year to date (€547 million), we believe that the sector will attract investors again. This confidence is illustrated by the Next Biotech Index, which has recovered from its Q4 18 low. Investors are demanding quality and market capitalisation is concentrated around mid-sized and large companies. We have seen some divergence between the US and Europe, due to structural listing-related factors.
Maturing clinical portfolios, more frequent positive news and an increased investor population are the first positive signals observed in the sector after several months.
Our Biotech Barometer released earlier this month describes these encouraging trends around one of the most innovative sectors on Euronext.
Euronext’s Post-Listing Advisory team gives three pieces of advice for biotech executives in the current environment:
- Reinforce your local investor base to be resilient against asset reallocation trends
- Choose the right capital structure for your business, and consider the benefits of both dilutive and non-dilutive financing to allow you to match investors’ allocation trends
- Know your investors: take any opportunity to talk with them, anticipate their expectations and investment strategies, but also provide them with your own valuable and scientific read across the biotech sector